Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle

Fabio Barra; Antonio Simone Laganà; Carolina Scala; Simone Garzon; Fabio Ghezzi; Simone Ferrero

doi:10.1016/j.rbmo.2020.07.022

Pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle

Fabio Barra, Antonio Simone Laganà, Carolina Scala, Simone Garzon, Fabio Ghezzi, Simone Ferrero

Reproductive biomedicine online · 2020 · vol. 41(5) , pp. 859–868 · doi:10.1016/j.rbmo.2020.07.022 · PMID:32873492 · W3043888440

article OA: green CC0 ⤵ 44 in-corpus citations

🔓 Open OA copy View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigated the efficacy of pretreatment with dienogest in women with endometriosis undergoing IVF after a previous failed cycle.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Endometriosis Fertilization in Vitro Hormone Antagonists Nandrolone Ovulation Induction Adult Birth Rate Embryo Transfer Endometriosis Female Fertilization in Vitro Hormone Antagonists Humans Nandrolone Nandrolone Oocyte Retrieval Ovulation Induction Pregnancy Pregnancy Rate Retrospective Studies

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (62)

Cited by (44)

Source provenance

europepmc: last seen: 2026-06-04T01:30:01.192114+00:00
openalex: last seen: 2026-06-10T16:23:13.998983+00:00
pubmed: last seen: 2026-05-13T22:21:42.008780+00:00

License: CC0 · commercial use OK

[1] Accuracy of transvaginal ultrasound for diagnosis of deep endometriosis in uterosacral ligaments, rectovaginal septum, vagina and bladder: systematic review and meta‐analysis via openalex

[2] A comparison of two months pretreatment with GnRH agonists with or without an aromatase inhibitor in women with ultrasound-diagnosed ovarian endometriomas undergoing IVF via openalex

[3] A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis via openalex

[4] Current and Emerging Therapeutics for the Management of Endometriosis via openalex

[5] Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis via openalex

[6] Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis via openalex

[7] Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis via openalex

[8] Dienogest in the treatment of endometriosis via openalex

[9] Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment via openalex

[10] Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex

[11] Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex

[12] Dienogest treatment after ovarian endometrioma removal in infertile women prior to IVF via openalex

[13] [Dienogest usefulness in pelvic pain due to endometriosis. A meta-analysis of its effectiveness]. via openalex

[14] Do endometriomas grow during ovarian stimulation for assisted reproduction? A three-dimensional volume analysis before and after ovarian stimulation via openalex

[15] Effect of Dienogest therapy on the size of the endometrioma via openalex

[16] Effect of GnRH agonist and letrozole treatment in women with recurrent implantation failure via openalex

[17] Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis via openalex

[18] Endometriomas: their ultrasound characteristics via openalex

[19] Endometriosis‐associated infertility: aspects of pathophysiological mechanisms and treatment options via openalex

[20] Endometriosis: the effects of dienogest via openalex

[21] Endometriosis: the effects of dienogest. via openalex

[22] Goserelin followed by assisted reproduction: results in infertile women with endometriosis. via openalex

[23] High rates of pregnancy after long-term down-regulation of women with severe endometriosis via openalex

[24] Impact of large ovarian endometriomas on the response to superovulation for in vitro fertilization: A retrospective study via openalex

[25] Implications of immune dysfunction on endometriosis associated infertility via openalex

[26] Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis via openalex

[27] Inflammatory cytokines IL-6, IL-10, IL-13, TNF-α and peritoneal fluid flora were associated with infertility in patients with endometriosis. via openalex

[28] Influence of Endometriosis on Assisted Reproductive Technology Outcomes via openalex

[29] Interventions for endometriosis-related infertility: a systematic review and network meta-analysis via openalex

[30] Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study via openalex

[31] Is there a critical endometrioma size associated with reduced ovarian responsiveness in assisted reproduction techniques? via openalex

[32] IVF-ICSI outcome in women operated on for bilateral endometriomas via openalex

[33] Laparoscopic surgery for endometriosis via openalex

[34] Long-Term Administration of Dienogest for the Treatment of Pain and Intestinal Symptoms in Patients with Rectosigmoid Endometriosis via openalex

[35] Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy via openalex

[36] Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis via openalex

[37] Long-term use of gonadotropin-releasing hormone analogues before IVF in women with endometriosis via openalex

[38] Management of Endometriosis in the Infertile Patient via openalex

[39] Management of Endometriosis in the Infertile Patient via openalex

[40] Management of recurrent implantation failure by gonadotropin-releasing hormone agonist and aromatase inhibitor suppression, in women without evidence of endometriosis via openalex

[41] Menotropin stimulation after prolonged gonadotropin releasing hormone agonist pretreatment for in vitro fertilization in patients with endometriosis via openalex

[42] Outcome of in vitro fertilization/intracytoplasmic sperm injection after laparoscopic cystectomy for endometriomas via openalex

[43] Ovarian stimulation and endometriosis progression or recurrence: a systematic review via openalex

[44] Pretreatment with gonadotrophin releasing hormone (GnRH) analogue prior to in vitro fertilisation for patients with endometriosis via openalex

[45] Progestin suppressed inflammation and cell viability of tumor necrosis factor‐α‐stimulated endometriotic stromal cells via openalex

[46] RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF via openalex

[47] Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex

[48] Spontaneous fertility after expectant or surgical management of rectovaginal endometriosis in women with or without ovarian endometrioma: a retrospective analysis via openalex

[49] The effect of endometriosis on <i>in vitro</i> fertilisation outcome: a systematic review and meta‐analysis via openalex

[50] The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis via openalex

[51] The impact of IVF on deep invasive endometriosis via openalex

[52] The impact of long-term gonadotropin-releasing hormone analogue treatment on preclinical abortions in patients with severe endometriosis undergoing in vitro fertilization-embryo transfer via openalex

[53] The value of pre-treatment with gonadotrophin releasing hormone (GnRH) analogue in IVF-ET therapy of severe endometriosis via openalex

[54] Transvaginal ultrasound <i>vs</i> magnetic resonance imaging for diagnosing deep infiltrating endometriosis: systematic review and meta‐analysis via openalex

[55] Treatment of endometrioma for improving fertility via openalex

[56] Ureteral obstruction and ruptured kidney following ovarian hyperstimulation syndrome via openalex

[57] W2996101359 via openalex

[58] W2131994528 via openalex

[59] W2146078576 via openalex

[60] W2124656409 via openalex

[61] W6774256961 via openalex

[62] W2146828785 via openalex